Response to Pham et al., "More data are needed to confirm the utility of screening for atypical fibroxanthoma and pleomorphic dermal sarcoma recurrence"

Mathias Ørholt*, Frank Eriksson, Mikkel Herly, Peter Vester-Glowinski

*Corresponding author af dette arbejde
OriginalsprogEngelsk
TidsskriftJournal of the American Academy of Dermatology
Vol/bind90
Udgave nummer5
Sider (fra-til)e175-e176
ISSN0190-9622
DOI
StatusUdgivet - 2024

Citationsformater